Summary. Ornithine decarboxylase activity was determined during the development of the peripheral auditory system in the murine otocyst with the goal of understanding the role of this enzyme in the morphological and functional maturation of the inner ear. At gestational days 11 and 12 enzyme activity was more than 10-fold higher than adult levels. A sharp decline occured between day 12 and 13 after which activity rose to a peak around day 15. Activity then dropped continuously until near-adult levels were reached at birth. A lower specific activity of ODC but a similar time-course was seen in otocysts explanted at gestational day 13 and subsequently cultured for 6 days. For two stages of development, enzyme activity and binding of 3H-c~-difluoromethylornithine were compared. The four-fold difference in enzymatic activity on gestational days ]5 and 17 was paralleled by a similar difference in binding. Ornithine decarboxylase activity during inner ear development therefore seems primarily regulated at the level of protein synthesis. Ornithine decarboxylase activity correlates with major inductive events in the morphogenesis of the cartilagenous otic capsule that serves as a template for the formation of the bony labyrinth. The pattern of activity may reflect the changes in the head mesenchyme that is recruited by the otocyst to aggregate and form its protective otic capsule.
Ornithine decarboxylase (ODC; EC 4.1.1.17) catalyzes the conversion of ornithine to putrescine, the rate limiting step in p01yamine synthesis. ODC activity is significantly higher in developing and regenerating tissues than in mature tissues, and the enzyme appears crucial to organ development and cellular repair in a number of systems (Fozard et al. ~980; Russell 1985) . Polyamines Offprint requests to: J. Schacht are important effectors of cellular mechanisms via DNA stabilization and synthesis (Hougaard and Larsson 1989; Slotkin et al. 1984) , regulation of protein synthesis (Slotkin et al. 1984) and of enzymes unrelated to polyamine pathways (Gilad and Gilad 1984) , membrane stabilization (Ballas et al. 1983) , and augmentation of receptor actions (Koenig et al. 1983 ). ODC activity is regulated by mechanisms which include feedback inhibition by polyamines (Pegg 1986 ), a protein inhibitor "antizyme" (Fong et al. 1976) , phosphorylation (Atmar and Kuehn 1981) , and induction by gene amplification and increased rate of translation (Hougaard and Larsson 1989) . This high degree of regulation suggests a critical role for ODC and polyamines in cellular function. ODC is ubiquitous and we have previously shown it to be present in tissues of the inner ear (Henley et al. 1987) .
Hearing loss has been reported in patients receiving the antitumor agent ~-difiuoromethylornithine (DFMO), a specific inhibitor of ODC (Sjoerdsma and Schechter 1984) , and DFMO-induced hearing loss has been confirmed in the guinea pig (Jansen et al. 1989) . Postnatal changes of ODC and a critical period for DFMO ototoxicity have been observed in the developing pigmented rat (Henley et al. 1990 ). However, a role of ODC in the development and function of the inner ear has not been established yet. This study was designed to investigate ODC activity during the prenatal development of the peripheral auditory system of the mouse with the goal of understanding the role of this enzyme in the morphological and functional maturation of the inner ear. The murine otocyst was chosen as the developmental model because of the major morphogenetic changes it undergoes during embryonic development (Van De Water 1984) .
Materials and methods

Tissue preparation
CBA males were bred with C57B16 females to yield CBA/C57B16 hybrid embryos. Timed pregnancies were obtained by the vaginal 548 plug method with the day of plug occurrence designated gestational day (gd) one. Actual embryonic age was determined by somite count until gd 13, thereafter by a combination of somite count and external features (Theiler 1972) .
Otocysts were excised from embryos of gd 11 through 18. Gravid mice were killed by cervical dislocation and the embryos removed and placed in Dulbecco's phosphate buffered saline (pH 7.4) kept at 4 ~ The otocyst, surrounding periotic mesenchyme, and cochlear-vestibular ganglion complex (CVG) were excised from embryos of gd 11 through 13. The otic capsule is a defined entity by gd 14, and from this time on the cartilaginous capsule, membranous labyrinth and the CVG complex were extirpated as a unit. Each specimen was placed into an individual test tube, quick-frozen in liquid nitrogen and stored at -70 ~ C.
For otocyst cultures, explants from embryos of gd 13 were maintained in 35 mm plastic dishes containing 1 ml of Newman & Tytell Serumless Medium supplemented with J0% heat-inactivated fetal calf serum. Six samples were cultured per dish and medium was completely exchanged every 48 hours. The culture chamber was kept at 37 ~ saturated humidity and a gas composition of 5 % CO 2 in room air. Upon termination of culture, the specimens were briefly washed in PBS, quick-frozen and stored at -70 ~ C as described for the in vivo specimens. An aliquot of the resulting supernatant was assayed for protein (Bradford 1976) . Another aliquot was combined with half as much volume of 2 mg bovine serum albumin/ml (to stabilize protein) and assayed for enzyme activity. All manipulations prior to the enzyme assay were done at 4 ~ C. ODC was assayed by a modification of the procedure of Russell and Snyder (1968) as previously described (Henley et al. 1987) . The supernatant fraction (1 to 12 gg of protein) was incubated at 37 ~ for 60 rain in closed incubation vessels in a total volume of 50 gl of (final concentrations) 50 mM HEPES, pH 7.2, 2 mM DTE, 0.1 mM EDTA, 0.2 mg BSA/gl, 50 ~M PLP, and 300 gM L-ornithine or DL-ornithine (L-[JJ4C] ornithine, 52.3 mCi/ mmole; DL-[ 1-14C] ornithine, 50.3 mCi/mmole; New England Nuclear, Wilmington, Del., USA). Five hundred p~M of c~-difluoromethyl-ornithine (DFMO; a gift from the Merrell Dow Research Institute, Cincinnati, Ohio, USA) was added to parallel incubations as a specific inhibitor of ODC. Incubations were terminated by the injection of 200 gl of 4 N t712SO 4 into the vessels and postincubated for at least 45 rain at room temperature to trap the evolving COz on to filters previously wetted with 40% KOH. The filters were then removed from the reaction vials, the KOH was neutralized with acetic acid, and radioactivity determined by liquid scintillation counting. Duplicates were run of each condition and ODC activity was determined as that fraction of total CO2 produced/hr/mg protein that was inhibited by DFMO.
Binding studies with tritiated DFMO were performed under conditions similar to that of the ODC activity assay. Three to four otocysts were homogenized in 165 gl of buffer and centrifuged as above. An aliquot of the supernatant was assayed for protein, another for ODC activity, and a third was used for the binding assay. For the binding assay, the supernatant was combined with DL-c~-[3,4-3H]-DFMO (26.6 Ci/mmol; New England Nuclear, Wilmington, Del., USA) at a final concentration of 1.4 gM. The sample was incubated for 60 min at 37 ~ removed to ice for approximately 5 min and then applied, at room temperature, to a column (4 mm x 25 cm) of Sephadex G-25-50 previously equilibrated with the assay buffer. Fractions of approximately 100 gl were collected, the protein-containing fractions were pooled and aliquots for total protein and radioactivity were taken. A second aliquot from the same supernatant was assayed for 3H-DFMO binding after preincubation at 37 ~ for 30 minutes with 500 gM unlabelled DFMO to correct for nonspecific binding.
Results
Three aspects of ODC activity were investigated: (1) the time course of ODC activity of the developing inner ear; (2) the correlation of 3H-DFMO binding with ODC enzymatic activity; (3) the time course of ODC activity in otocysts explanted at gd J 3 and cultured in vitro.
ODC activity during development in vivo
The activity of ODC in otocysts changed significantly during development of the inner ear (Fig. l) . The ODC activity was expressed as enzymatic activity per mg protein to correct for changes due to increase in total otocyst mass. In addition, individual otocysts were ranked by protein content or weight to control for the possibility that otocysts from a given "gestational day" included specimens of slightly different development stages. Such a ranking should more accurately reflect subtle and discrete changes during development. However, comparison of the data revealed that the changes in ODC activity were evident regardless of the normalization procedure.
For comparison of ODC in the developing otocyst with that in the mature cochlea, the enzyme was analyzed in cochlear tissues of mature 44-day old mice. ODC activity was found to be 134_+23 pmoles CO2 formed/mg protein/h. In contrast, activity in the developing ototcyst (gd 11 and 12) was more than 10-fold higher. A sharp decline in ODC activity occured between day 12 and 13 after which activity rose to a peak around gd 15 (significance of difference between day 13 and 15: 0.05<P<0.1). At this stage, activity dropped continuously until near-adult levels were reached at birth. 
Binding of radiolabelled DFMO
For two stages of development, aliquots of the enzyme fractions were assayed for binding of 3H-DFMO and ODC activity. Gestational days 15 and 17 were selected as they corresponded to a peak and a trough in enzymatic activity. The approximately four-fold difference in ODC activity was paralleled by a similar difference in the specific binding of 3H-DFMO (Table 1) .
ODC activity during development in vitro
The third aspect of this study addressed the question whether the in vitro system reflected the pattern of ODC activity in vivo. Otocysts were explanted at gd 13 and cultured for 6 days (144 h). The specific activity of ODC dropped rapidly after the otocyst was explanted (Fig. 2 ) and rose to a peak after 48 h (significance, P<0.01). This time corresponds to the second division in vitro.
At 144 h in vitro, ODC values were similar to those in otocysts in vivo at day 18 to 19.
Discussion
The time course of ODC activity shows a clear and distinct pattern of peaks and troughs during development of the inner ear. Although more prominently displayed in vivo, activity changes are also present in the organ culture of the otocyst. The major questions arising from this first study of ODC in the developing inner ear are:
(1) what mechanism(s) determine the time course of enzymatic activity and (2) what aspects of development are controlled by ODC. Two mechanisms may account for the peaks and troughs in ODC activity during development: (1) changes in the amount of enzyme (due to induction of its synthesis); (2) variations in the activity of the enzyme due to inhibition by regulators such as a specific antizyme. The enzyme assay based on decarboxylation of ornithine determines the activity of ODC, whereas binding of the specific inhibitor DFMO reflects the amount of ODC protein present. Thus, as the binding of DFMO parallels the peak and trough seen in the enzyme assays, the variation in ODC activity appears to be based upon varying concentrations of the enzyme. ODC activity during inner ear development therefore seems primarily regulated at the level of protein synthesis.
The second question is more difficult to address and will require further detailed studies. During the period studied, tissue interactions modulate the developmental rates of both the epithelial and mesenchymal tissues that eventually form the membranous and bony labyrinths (McPhee and Van de Water 1986 ). There are also major shifts in the synthesis of matrix molecules that are involved in the formation of the cartilagenous otic capsule and the perilymphatic spaces (D' Amico-Martel et al. 1987; McPhee and Van De Water 1985) . A few correlations appear obvious. High ODC levels on day 11 correspond to high levels of cellular proliferation in the surrounding periotic mesenchyme which occurs just prior to the aggregation phase of otic capsule development between the 1 l th and 12th gd. On the 12th gd, during which ODC levels are still elevated, periotic mesenchyme is aggregated and an extracellular matrix is actively being produced by the prechondrogenic mesenchyme (McPhee and Van De Water 1985; 1986) . During gd 13 a large subset of cells of the aggregated periotic mesenchyme are involved in the formation of the perilymphatic spaces (McPhee et al. 1987 ). This coincides with the decrease in ODC activity. Between days 14 and 16 of gestation a mature cartilaginous capsule is produced coinciding with the peaks of ODC activity between gestation days 14 and 15.
The ODC inhibitor DFMO in combination with the in vitro system should provide a valuable tool in the further elucidation of possible connections between ODC activity and specific features of otocyst morphogenesis. Otocysts undergo morphogenesis in culture as they do in vivo, although some specific features such as tight junctions may not reach the same degree of maturity (Berggren et al. 1987) . ODC levels in vitro reflect the changes of enzyme activity in vivo. The precipitous drop of enzyme activity after explantation at gd 13 is consistent with observations in other explanted organ systems (Huber and Brown 1982) . Division 2 which corresponds to gd 15 in the in vivo development shows a clear peak of activity albeit of lower absolute activity than in vivo. If the application of DFMO leads to dysmorphogenesis at specific stages of development, correlations may be drawn between inhibition of ODC activity and the disruption of normal morphogenetic expression. A similar experimental approach using a proline antagonist was successful in studying the role of proline synthesis during development of otic explants (Van De Water and Galinovic-Schwartz 1986) .
In conclusion, ODC activity appears to correlate with major inductive events in the morphogenesis and formation of the cartilagenous otic capsule that serves as a template for the formation of the bony labyrinth. ODC activity may reflect the changes in the head mesenchyme that is recruited by the otocyst to aggregate and form its protective otic capsule.
